NICARDIPINE HYDROCHLORIDE Recall D-0390-2024
Description: Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10
NICARDIPINE HYDROCHLORIDE Recall D-0390-2024 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0390-2024 |
| Event ID | 94073 |
| Brand | NICARDIPINE HYDROCHLORIDE |
| Generic Name | NICARDIPINE HYDROCHLORIDE |
| Manufacturer | NICARDIPINE HYDROCHLORIDE |
| Original Package? | 1 |
| Active Substance | NICARDIPINE HYDROCHLORIDE |
| Drug Route | INTRAVENOUS |
| Distribution | Nationwide within the United States |
| Quantity | 335,940 vials |
| Recall Reason | Failed Impurities/Degradation Specifications: Out of specification for organic impurities |
| Drug Classification | Class II |
| Drug Code Info | 20240327 |
| Product NDC | 55150-183 |
| Drug UPC | 0355150183012 |
| Recall Initiation Date | 20240220 |
| Report Date | 20240327 |
| Classification Date | 20240319 |
| Address | 279 Princeton Hightstown Rd East Windsor, NJ 08520-1401 United States |
| Recalling Firm | Eugia US LLC |
| Initial Notification | Letter |
| Unique Ingredient Identifier | K5BC5011K3 |
| Drug Application Number | ANDA211121 |
| Structured Product Labeling (SPL ID) | c5ead57c-6f9e-41f5-b9cc-04c4c3abbcc9 |
| Structured Product Labeling (SPL Set ID) | dcd7d173-4d8e-4282-9edf-817711340e43 |
| Similar To |